4Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Sell
8,271
-375
-4% -$87.4K 1.64% 12
2026
Q1
$2.1M Sell
8,646
-256
-3% -$59.6K 1.79% 11
2025
Q4
$1.84M Sell
8,902
-209
-2% -$41.3K 1.57% 13
2025
Q3
$1.69M Buy
9,111
+206
+2% +$35.3K 1.51% 16
2025
Q2
$1.36M Sell
8,905
-51
-0.6% -$7.84K 1.38% 17
2025
Q1
$1.49M Sell
8,956
-2,177
-20% -$341K 1.62% 15
2024
Q4
$1.61M Buy
+11,133
New +$1.73M 1.61% 12

Other funds holding JNJ

4Wealth Advisors's JNJ Position: Q2 2026 in Review

4Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 4.3% in Q2 2026, selling an estimated $87.4K and leaving 8,271 shares worth $2.14M. The position accounts for 1.64% of the portfolio, ranked #12.

4Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • 4Wealth Advisors held 8,271 shares of Johnson & Johnson worth $2.14M as of Q2 2026.
  • 4Wealth Advisors sold 375 Johnson & Johnson shares in Q2 2026, an estimated $87.4K.
  • Johnson & Johnson made up 1.64% of 4Wealth Advisors's portfolio in Q2 2026, its #12 holding.
  • 4Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on 4Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.